U.S. License Holder:
Genentech
Date of License:
December-30-1993
Last Update:
Nov-30-2024
FDA-Approved Indications
PULMOZYME (dornase alfa) is a recombinant DNase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function.